From: A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Article name | Corr. author | DOI | Accesses |
---|---|---|---|
Cerebral microbleeds: overview and implications in cognitive impairment | Sergi Martinez-Ramirez et al. | 17,167 | |
Testing a MultiTEP-based combination vaccine to reduce A-beta and tau pathology in Tau22/5xFAD bigenic mice | Hayk Davtyan et al. | 14,241 | |
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures | Jeffrey L Cummings et al. | 7209 | |
Herbal therapy: a new pathway for the treatment of Alzheimer’s disease | Jinzhou Tian et al. | 6715 | |
Alzheimer’s disease prevention: from risk factors to early intervention | Marta Crous-Bou et al. | 6230 | |
Souvenaid in the management of mild cognitive impairment: an expert consensus opinion | Jeffrey Cummings et al. | 5890 | |
Comprehensive treatment of dementia with Lewy bodies | Brendon P Boot | 5734 | |
The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis | Paul C Donaghy et al. | 5031 | |
Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)—study protocol for a randomized controlled trial | Miranka Wirth et al. | 4854 | |
Alcohol use and dementia: a systematic scoping review | Jürgen Rehm et al. | 4714 |